Trial Profile
An open label trial of ziprasidone as an adjuvant for clozapine- or olanzapine-associated diabetes mellitus or impaired fasting glucose in chronic schizophrenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary) ; Clozapine; Olanzapine
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- 20 Nov 2006 New trial record.